Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2014-05-15, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20140515/10-Q/1/000.htm SEC Original: v378239_10q.htm

---

---

Webplus: SKBI/20140515/10-Q/2_EX-10.3/000.htm SEC Original: v378239_ex10-3.htm
CONSULTING SERVICES AGREEMENT Agreement Company Consultant This CONSULTING SERVICES AGREEMENT (this “ RECITALS: WHEREAS, Board Representative WHEREAS Prior Consulting Agreement WHEREAS WHEREAS NOW, THEREFORE, in consideration of the foregoing recitals and the mutual agreements herein contained and for other good and valuable consideration, the Parties hereto agree as follows: 1. Continuing Services as the Representative Services Prior to This Agreement

---

---

Webplus: SKBI/20140515/10-Q/3_EX-31.1/000.htm SEC Original: v378239_ex31-1.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20140515/10-Q/4_EX-31.2/000.htm SEC Original: v378239_ex31-2.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20140515/10-Q/5_EX-32.1/000.htm SEC Original: v378239_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2014 Weibing Lu Chief Executive Officer

---

---

Webplus: SKBI/20140515/10-Q/6_EX-32.2/000.htm SEC Original: v378239_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2014 Bing Mei Chief Financial Officer

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2014-05-15, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE